TLPPF News and Press, Telix Pharmaceuticals Ltd From 02/22/24

2024-02-22 23:36:10 ET Telix Pharmaceuticals Limited (TLPPF) Q4 2023 Earnings Conference Call February 22, 2024 17:00 ET Company Participants Kyahn Williamson - Senior Vice President of Investor Relations & Corporate Communications Christian Behrenbruch - Managin...

2024-02-22 17:47:47 ET More on Telix Pharmaceuticals QSAM to be acquired by Telix for $33.1M plus $90M CVR Historical earnings data for Telix Pharmaceuticals Financial information for Telix Pharmaceuticals Read the full article on Seeking Alpha For fu...

MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP ( 153 Sm-DOTMP). QSAM i...

2024-02-07 16:23:47 ET More on QSAM Biosciences QSAM Biosciences signs term sheet to be acquired by Telix Pharmaceuticals Financial information for QSAM Biosciences Read the full article on Seeking Alpha For further details see: QSAM to be acquired by Tel...

MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 202...

MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix” or the “Company”) today announces that it is considering an initial public offering (“IPO”) of American Depositary Shares (“ADSs”) repres...

MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) --  Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA (US...

2023-10-19 11:20:59 ET More on Telix Pharmaceuticals Historical earnings data for Telix Pharmaceuticals Financial information for Telix Pharmaceuticals For further details see: Telix Pharmaceuticals reports Q3 results

2023-08-23 12:06:48 ET More on Telix Pharmaceuticals Eli Lilly inks licensing deal for cancer therapy with Australian biotech Telix Seeking Alpha Catalyst Watch Earnings data for Telix Pharmaceuticals For further details see: Telix Pharmaceuticals reports...

2023-04-17 14:33:31 ET Telix Pharmaceuticals press release ( OTCPK:TLPPF ): Q1 Revenue of A$100.1M. cash balance of A$121.4M Demand for Illuccix in the United States continues to increase with sales of $97.5M (up from $76.8M in the prior quarter) Second conse...